Revvity Inc (RVTY) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive signals such as recent congressional purchases and a modest price increase, the technical indicators, options sentiment, and analyst ratings suggest a neutral to slightly cautious outlook. The stock is trading near the top of its historical valuation range, and there are no strong proprietary trading signals or news catalysts to justify immediate action.
The MACD is below zero and negatively contracting, indicating bearish momentum. RSI is neutral at 49.278, and moving averages are converging, showing no clear trend. The stock is trading below the pivot point of 101.182, with key support at 97.61 and resistance at 104.754.

Congressional trading data shows two recent purchase transactions with a median amount of $4.1M, indicating strong confidence from influential figures. Additionally, Barclays raised its price target to $105, and TD Cowen highlighted improving demand and management confidence.
Analyst sentiment is mixed, with some firms lowering price targets and expressing concerns about valuation and margin risks. Wolfe Research noted the stock is at the top of its historical valuation range. Technical indicators do not support a strong upward trend, and options data shows bearish short-term sentiment.
Financial data for the latest quarter is unavailable, making it difficult to assess growth trends or profitability. However, analyst commentary suggests improving Pharma/A&G demand and software strength.
Analyst ratings are mixed, with a combination of Buy, Neutral, and Hold ratings. Price targets range from $90 to $120, with the average leaning towards a cautious outlook. Wolfe Research and Stifel highlight valuation concerns, while TD Cowen and Baird remain optimistic about growth prospects.